drugset / Trial / NCT07137689
A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to help determine the right dose of LY3537982 in participants with kidney problems, particularly those with severe kidney problems. The study will last about 43 days for each participant.
Timeline
- Start
- 2025-08-18
- Primary completion
- 2026-04-10
- Completion
- 2026-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olomorasib | Small molecule | — | Oral |